SENA Health Secures Series A Funding to Scale AI Care Coordination

The capital injection will fuel a broader expansion of SENA’s business development and sales initiatives while accelerating ongoing R&D in artificial intelligence. By integrating intelligent automation with clinical oversight, the company’s 24/7 command center manages front-desk and back-office functions that traditionally consume significant administrative resources. This approach intends to allow providers to redirect their focus toward patient outcomes rather than manual workflows.

As part of the agreement, Rittenhouse Ventures partner Sushma Rajagopalan will join the SENA Health Board of Directors. Dr. Anthony Wehbe, CEO and founder of SENA, emphasized that the partnership provides more than just capital, citing Rittenhouse’s operational guidance as a critical asset for the company’s next phase of growth. The firm, which typically targets B2B SaaS and tech-enabled services, will assist SENA as it scales its infrastructure to meet rising demand from healthcare organizations seeking to simplify complex care delivery models.